Overview
Given the correlation between food cravings and body weight, a number of obesity medications have been studied to determine how they affect food cravings. In a research on weight loss using Medifast meal replacements, those taking phentermine shed a higher percentage of weight ( 3.3%) and had a bigger decrease in the FCI's fat and sweets subcategories. Food cravings were reduced in a dose-dependent way when phentermine (15 g 1 or 2 times/day) was combined with lorcaserin (Belviq) (10 mg twice daily). Semaglutide, a GLP-1 counterpart that bears similarities to liraglutide, has been the subject of recent research. Based on the CoEQ, it was given for 12 weeks and reduced appetite and food cravings.Since bupropion (Contrave), naltrexone, and liraglutide (Saxenda) have all shown comparable decreases in cravings, they could all be promising treatment targets. Significantly, it has been demonstrated that pharmacologic treatments lessen cravings. investigated the impact of food cravings in patients receiving medication to help them lose weight. Early determinants of weight loss were examined using the CoEQ. The most important predictor of BMI slope was craving control. Moreover, both responders and non-responders looked to desire control. There was a notable variation in the weight reduction between the groups by the first time point evaluated, which was eight weeks. For 56 weeks, this went on. Craving management is a hypothetical modifier that might be useful for people who don't lose weight as well during the first phase of weight reduction.For those with strong cravings who are attempting to lose or maintain weight, many obesity medications have the potential to decrease cravings. But more research is needed to fully understand how the conditioning theory of food cravings and the mechanism(s) of action for reducing food cravings with these medications work. People are probably consuming meals they don't crave as frequently, but this is undoubtedly an important subject for more research.If you want to overpower obesity both spiritual and physical in the journey of life click on the buy button now.
Full Product Details
Author: Paul B Evans
Publisher: Independently Published
Imprint: Independently Published
Dimensions:
Width: 15.20cm
, Height: 0.70cm
, Length: 22.90cm
Weight: 0.177kg
ISBN: 9798879833508
Pages: 126
Publication Date: 16 February 2024
Audience:
General/trade
,
General
Format: Paperback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
